Cadre Holdings, Inc.

Cadre Holdings, Inc. (CDRE) Stock Analysis

$26.380

+0.467 (+1.77%)At close

Loading chart…
High
26.530
Open
26.050
VWAP
26.19
Volume
502.30K
Mkt Cap
1.34B
Low
25.670
Amount
13.16M
EV/EBITDA, TTM
11.68

Cadre Holdings, Inc. is engaged in the manufacturing and distribution of safety products. The Company's equipment provides protection to allow users to safely perform their duties and protect those around them in hazardous or life-threatening situations. Its core products include body armor, explosive ordnance disposal equipment, duty gear and nuclear safety products. Its principal body armor product offerings include concealable, corrections and tactical armor, which provide varying levels of protection against ballistic or sharp instrument threats. It offers an engineered portfolio of critical operator survival suits, blast sensors, accessories and vehicle blast attenuation seats for bomb safety technicians, among others. Its engineered products are utilized in over 100 countries by federal, state and local law enforcement, fire and rescue professionals, explosive ordnance disposal teams, and emergency medical technicians. Its key brands include Safariland and Med-Eng, among others.

AI analysis of Cadre Holdings, Inc. (CDRE)

Buy

Cadre Holdings Inc is a good buy right now due to its recent positive performance and strong analyst ratings. The stock has seen a 7.45% increase over the last five days, and analysts have set a price target of $43, suggesting a potential upside of 63.1%. Additionally, the forward P/E ratio of 18.15 indicates that the stock may be undervalued compared to its growth prospects. However, the main risk is the recent insider selling by CEO Warren B. Kanders, who sold 75,000 shares, which could signal a lack of confidence in the company's near-term performance.

Valuation Metrics

The current forward P/E ratio for Cadre Holdings, Inc. (CDRE) is 18.15, compared to its 5-year average forward P/E of 30.26.

Forward P/E

Fair
5Y Average P/E
30.26
Current P/E
18.15
Overvalued
46.25
Undervalued
14.27

Forward EV/EBITDA

Fair
5Y Average EV/EBITDA
13.22
Current EV/EBITDA
11.68
Overvalued
15.05
Undervalued
11.39

Forward P/S

Undervalued
5Y Average P/S
2.01
Current P/S
1.37
Overvalued
2.34
Undervalued
1.68

Alphio AI Price Scenarios for CDRE

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%CDRE

$34.59

Scenario price

B

Base

Base · 50%CDRE

$30.16

Scenario price

B

Bear

Bear · 25%CDRE

$29.75

Scenario price

Whales holding CDRE

G

Greenhouse Funds LLLP

+ HoldingCDRE

-0.40%

3M Return

Events Timeline

2026-08-05 (ET)

16:30:00

Cadre Raises 2026 Sales Guidance to $749-$769 Million

16:30:00

Company Reports Q2 Revenue of $207.1M, Exceeding Expectations

2026-06-02 (ET)

16:20:00

Cadre Holdings Subsidiary Safariland Wins $61 Million FBI Contract

2026-05-11 (ET)

16:30:00

Cadre Reports Q1 Revenue of $155.4M, Exceeds Expectations

16:30:00

Company Confirms FY26 Adjusted EBITDA View of $136M-$141M

News

CDRE FAQ — answered by Alphio AI

Cadre Holdings, Inc. is engaged in the manufacturing and distribution of safety products. The Company's equipment provides protection to allow users to safely perform their duties and protect those around them in hazardous or life-threatening situations. Its core products include body armor, explosive ordnance disposal equipment, duty gear and nuclear safety products. Its principal body armor product offerings include concealable, corrections and tactical armor, which provide varying levels of protection against ballistic or sharp instrument threats. It offers an engineered portfolio of critical operator survival suits, blast sensors, accessories and vehicle blast attenuation seats for bomb safety technicians, among others. Its engineered products are utilized in over 100 countries by federal, state and local law enforcement, fire and rescue professionals, explosive ordnance disposal teams, and emergency medical technicians. Its key brands include Safariland and Med-Eng, among others. It operates in the Industrials sector (ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUP industry).

Cadre Holdings Inc is a good buy right now due to its recent positive performance and strong analyst ratings. The stock has seen a 7.45% increase over the last five days, and analysts have set a price target of $43, suggesting a potential upside of 63.1%. Additionally, the forward P/E ratio of 18.15 indicates that the stock may be undervalued compared to its growth prospects. However, the main risk is the recent insider selling by CEO Warren B. Kanders, who sold 75,000 shares, which could signal a lack of confidence in the company's near-term performance.

Community

More ↗

No posts yet

Sign up or log in to join the discussion

This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.

Start trading